Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 901–1,000 of 1,001
Wright, A. P. H., & Gustafsson, J.-Å. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49894-3 · Cited by 25
Vormfelde, S. V., Burckhardt, G., Zirk, A., Wojnowski, L., & Brockmöller, J. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.6.701.22817 · Cited by 25
Aldosterone antagonists in the treatment of hypertension and target organ damage
Rajagopalan, S., & Pitt, B. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0046-2 · Cited by 25
“The most well understood mechanism involves the action of the nicotinamide adenine dinucleotide‐ dependent type II isoform of the enzyme 11β-hydroxysteroid dehydrogenase (11β-HSD-2) [ 6 ].”
BackgroundFeatures of the shuttle pair 11β-hydroxyprogesterone-11-ketoprogesterone
Galigniana, M. D., Vicent, G. P., Burton, G., & Lantos, C. P. (1997) · Steroids · doi:10.1016/s0039-128x(96)00244-9 · Cited by 25
Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues
Morris, D. J., Souness, G. W., Brem, A. S., & Rafestin-Oblin, M. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00977.x · Cited by 25
Baker, M. E. (1994) · Biochemical Journal · doi:10.1042/bj3010311 · Cited by 25
Yang, K., & Matthews, S. G. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03574-q · Cited by 25
Renal 11β-hydroxysteroid dehydrogenase activity: Effects of age, sex and altered hormonal status
Smith, R. E., & Funder, J. W. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90135-r · Cited by 25
Self-citationSexual Dimorphism of Corticosteroid Signaling during Kidney Development
Laulhé, M., Dumeige, L., Vu, T. A., Hani, I., Pussard, E., Lombès, M., Viengchareun, S., & Martinerie, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105275 · Cited by 24
Rodela, T. M., McDonald, M. D., Walsh, P. J., & Gilmour, K. M. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.026997 · Cited by 24
“that aldosterone infusion in toadfish may have activated pathways that are normally insensitive to cortisol activation (which is also an agonist of the MR) as a result of the expression of 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), an enzyme that catalyzes the conversion of cortisol to mineralocorticoid recep…”
BackgroundInfluentialCardoso, B. V., Mesquita, F. F., Gontijo, J. A. R., & Boer, P. A. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313481081 · Cited by 24
Pathology of Aldosterone Biosynthesis and its Action
Gao, X., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Suzuki, T., Satoh, F., & Sasano, H. (2021) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.254.1 · Cited by 24
“…cortisol to cortisone which has little binding affinity to MR and has been reported to be co-localized with MR in almost all human tissues by our group (Edwards et al. 1988; Funder et al. 1988; Hirasawa et al. 1997, 1999, 2000; Stewart et al. 1987; Suzuki et al. 1998; Takahashi et al. 1998).”
BackgroundDisorders of Potassium Metabolism
Weiner, I. D., Linas, S. L., & Wingo, C. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05876-6.00009-5 · Cited by 24
Racial differences in aldosterone excretion: a longitudinal study in children
Pratt, J. H., Manatunga, A. K., Bloem, L. J., & Li, W. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263135 · Cited by 24
Thompson, A., Bailey, M. A., Michael, A. E., & Unwin, R. J. (2000) · Nephron Experimental Nephrology · doi:10.1159/000020647 · Cited by 24
“It is believed that glucocorticoids are prevented from binding to MR by the enzyme 11β-hydroxysteroid dehydrogenase (11βHSD) which converts the high-affinity glucocorticoids to their inactive 11-ketosteroid metabolites (cortisol to cortisone in humans, corticosterone to 11-dehydrocorticosterone in rodents) [”
BackgroundLiu, Y., Nakagawa, Y., & Ohzeki, T. (1998) · Hypertension · doi:10.1161/01.hyp.31.3.885 · Cited by 24
Distal tubular electrolyte transport during inhibition of renal 11β-hydroxysteroid dehydrogenase
Biller, K. J., Unwin, R. J., & Shirley, D. G. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.1.f172 · Cited by 24
“This hypothesis has received considerable support from in vitro experiments (3, 11, 20) and from the observation that individuals with mutations of the gene encoding 11b-HSD2 display the syndrome of apparent mineralocorticoid excess, a condition characterized by Na(1) retention, hypertension, and hypokalemia in the ab…”
BackgroundResult11β‐HYDROXYSTEROID DEHYDROGENASE ACTIVITY IN MESENTERIC ARTERIES OF SPONTANEOUSLY HYPERTENSIVE RATS
Takeda, Y., Yoneda, T., Miyamori, I., Gathiram, P., & Takeda, R. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01644.x · Cited by 24
Cloning of the 11βHSD type II enzyme from human kidney
Albiston, A. L., Smith, R. E., Obeyesekere, V. R., & Krozowski, Z. S. (1995) · Endocrine Research · doi:10.3109/07435809509030456 · Cited by 24
Self-citationCanny, B. J. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90067-i · Cited by 24
Apparent mineralocorticoid excess syndromes
Shimojo, M., & Stewart, P. M. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349763 · Cited by 23
Guo, J., Deng, H., Li, H., Zhu, Q., Zhao, B., Chen, B., Chu, Y., & Ge, R. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.01.002 · Cited by 23
MR/GR Signaling in the Brain during the Stress Response
de Kloet, E. R., & Meijer, O. C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87234 · Cited by 24
Yakirevich, E., Morris, D. J., Tavares, R., Meitner, P. A., Lechpammer, M., Noble, L. C., de Rodriguez, A. F., Gómez-Sánchez, C. E., Wang, L., Sabo, E., et al. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31815f2362 · Cited by 23
“11b-HSD2 is a NAD-dependent dehydrogenase, which catalyzes the conversion of active cortisol to inactive metabolite cortisone, thus protecting the nonselective MR from interaction with glucocorticoids.(1,2,10,11) MR and 11b-HSD2 are coexpressed in the normal human kidney in the distal convoluted tubules, collecting du…”
BackgroundHypercortisolism in Obesity-Associated Hypertension
Varughese, A. G., Nimkevych, O., & Uwaifo, G. I. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0443-y · Cited by 23
De‐An, P., Li, L., Xu, Z., Jin‐Yu, H., Zheng-Ming, X., Wang, M., Qiang, Y., & Shi‐eng, H. (2010) · Clinical Cardiology · doi:10.1002/clc.20689 · Cited by 23
Kinoshita, H., Okabayashi, M., Kaneko, M., Yasuda, M., Abé, K., Machida, A., Ohkubo, T., Kamata, T., & Yakushiji, F. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2008.0397 · Cited by 23
Pagé, N., Warriar, N., & Govindan, M. V. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90008-6 · Cited by 23
Frey, F. J. (2006) · Hepatology · doi:10.1002/hep.21381 · Cited by 23
Target tissue specificity of mineralocorticoids
Funder, J. W. (1990) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(90)90026-y · Cited by 23
Self-citationBistrup, C., Thiesson, H. C., Jensen, B. L., & Skøtt, O. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01428.x · Cited by 23
Thiesson, H. C., Jensen, B. L., Bistrup, C., Ottosen, P. D., McNeilly, A. D., Andrew, R., Seckl, J. R., & Skøtt, O. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00418.2005 · Cited by 23
“Glucocorticoids and aldosterone bind with equal affinity to the mineralocorticoid receptor (MR) in vitro, and cortisol (in humans) and corticosterone in (rats ad mice) circulate at 100–1,000 times the level of aldosterone in plasma (11, 15).”
BackgroundSocial regulation of cortisol receptor gene expression
Korzan, W. J., Fernald, R. D., & Grone, B. P. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.104430 · Cited by 23
“In mammals, MR binds cortisol and aldosterone equally (Funder et al., 1988); however, teleost fish do not produce aldosterone and MR is highly responsive to cortisol and may act as a cortisol or 11-deoxycortiscosterone receptor in vivo (Sturm et al.”
BackgroundInvestigation of the mechanism of hypertension in apparent mineralocorticoid excess
Speiser, P., Riddick, L., MARTIN, K. O., & New, M. I. (1993) · Metabolism · doi:10.1016/0026-0495(93)90057-u · Cited by 23
Glorioso, N., Filigheddu, F., Parpaglia, P. P., Soro, A., Troffa, C., Argiolas, G., & Mulatero, P. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi070 · Cited by 23
Slight, S. H., Chilakamarri, V. K., Nasr, S., Dhalla, A. K., Ramires, F. J. A., Sun, Y., Ganjam, V. K., & Weber, K. T. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006844010371 · Cited by 23
Guinea pig 11β-hydroxysteroid dehydrogenase type 1: primary structure and catalytic properties☆
Pu, X.-D., & Yang, K. (2000) · Steroids · doi:10.1016/s0039-128x(99)00098-7 · Cited by 23
CORTICOSTEROIDS IN ESSENTIAL HYPERTENSION: MULTIPLE CANDIDATE LOCI AND PHENOTYPIC VARIATION
Connell, J., Kenyon, C. J., Ingram, M. C., Holloway, C., Jamieson, A., Panarelli, M., Inglis, G., & Fräser, R. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb02743.x · Cited by 23
Aziz, N., Brown, D., Lee, W. S., & Náray‐Fejes‐Tóth, A. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940387 · Cited by 23
Analysis of glucocorticoid and mineralocorticoid signalling by gene targeting
Berger, S., Cole, T. J., Schmid, W., & Schütz, G. (1996) · Endocrine Research · doi:10.1080/07435809609043758 · Cited by 23
Co-expression of two distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine placenta
Yang, K. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)00179-p · Cited by 23
Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms
Allingham, M. J., Mettu, P. S., & Cousins, S. W. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107788 · Cited by 22
Licorice Extract Does Not Impair the Male Reproductive Function of Rats
Shin, S., Jang, J. Y., Choi, B.-I., Baek, I., Yon, J., Hwang, B. Y., Park, D., Jeon, J. H., Nam, S.-Y., Yun, Y. W., et al. (2008) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.57.11 · Cited by 22
Inderbinen, S. G., Zogg, M., Kley, M., Smieško, M., & Odermatt, A. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115387 · Cited by 22
Why do humans have two glucocorticoids: A question of intestinal fortitude
Morris, D. J. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.017 · Cited by 22
Ackermann, D., Mordasini, D., Cheval, L., Imbert–Teboul, M., Vogt, B., & Doucet, A. (2007) · Hepatology · doi:10.1002/hep.21699 · Cited by 22
Pivotal Role of the Kidney in Hypertension
Hamm, L. L., & Hering-Smith, K. S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e590f0 · Cited by 23
Speake, P. F., Glazier, J. D., Greenwood, S. L., & Sibley, C. P. (2010) · Placenta · doi:10.1016/j.placenta.2009.12.025 · Cited by 22
“However, in mineralocorticoid target tissues the MR is usually protected from the effects of cortisol by the presence of an enzyme, 11-b-hydroxysteroid dehydrogenase-2 (11-b-HSD-2), which converts cortisol to inactive cortisone [10,14].”
BackgroundCorticosterone Metabolism and Effects on Angiotensin II Receptors in Vascular Smooth Muscle
Ullian, M. E., & Walsh, L. G. (1995) · Circulation Research · doi:10.1161/01.res.77.4.702 · Cited by 22
Mineralocorticoid-receptor blockade, hypertension and heart failure
Funder, J. W. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0016 · Cited by 22
“In epithelia (and in vascular smooth muscle cells and endothelial cells) the receptors are 'protected' by the enzyme 11-β-hydroxysteroid dehydrogenase type II, which converts cortisol to receptor-inactive cortisone”
BackgroundSelf-citationOnyimba, C., Vijapurapu, N., Curnow, J., Khosla, P., Stewart, P. M., Murray, P. I., Walker, E. A., & Rauz, S. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06840 · Cited by 22
“A second dehydrogenase isozyme (11b-HSD2) protects the mineralocorticoid receptor (MR) from cortisol excess by inactivating it to cortisone (Funder et al. 1988).”
BackgroundNørregaard, R., Uhrenholt, T. R., Bistrup, C., Skøtt, O., & Jensen, B. L. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00061.2003 · Cited by 22
“Selectivity of aldosterone over glucocorticoids is conferred by 11- -hydroxysteroid dehydrogenase-2 (11 HSD-2), which metabolizes hydroxy-glucocorticoids to inactive ketoglucocorticoids and thereby prevents illicit receptor binding by glucocorticoids (13, 18).”
BackgroundEffects of carbenoxolone on alveolar fluid clearance and lung inflammation in the rat
Suzuki, S., Matsuda, Y., Sugawara, T., Tabata, T., Ishibashi, H., Hoshikawa, Y., Kubo, H., & Kondo, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000139621.74965.fb · Cited by 22
Purification and characterization of the activated mineralocorticoid receptor from rat myocardium
Lázár, G., Pagano, M., & Agarwal, M. K. (1990) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(90)90192-y · Cited by 22
Morris, D. J., Lo, Y. H., Litchfield, W. R., & Williams, G. H. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.469 · Cited by 22
Hastings, N. B., Orchinik, M., Aubourg, M. V., & McEwen, B. S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7050 · Cited by 22
Bannenberg, G., Martin, H.-J., Bélai, I., & Maser, E. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00183-7 · Cited by 22
Expression of 11β-hydroxysteroid dehydrogenase mRNA in rat vascular smooth muscle cells
Takeda, Y., Miyamori, I., Yoneda, T., Ito, Y., & Takeda, R. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00818-3 · Cited by 22
Apparent Mineralocorticoid Excess
Funder, J. W. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30034-3 · Cited by 22
Self-citationEvidence for Cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess
Tedde, R., Pala, A., Melis, A., & Ulick, S. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348778 · Cited by 22
Aldosterone-sensitive neurons in the nucleus of the solitary: efferent projections.
Geerling, J. C., & LOEWY, A. (2006) · PubMed · Cited by 22
Madaro, A., Kristiansen, T. S., & Pavlidis, M. A. (2020) · Animal welfare · doi:10.1007/978-3-030-41675-1_11 · Cited by 21
Endocrinology of the Stress Response During Critical Illness
Marik, P. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00076-5 · Cited by 21
Active Cushing Disease Is Characterized by Increased Adipose Tissue Macrophage Presence
Lee, I. T., Opata, A. A., EĞRİTAĞ, H. E., Wang, L., Donovan, M. J., Buettner, C., & Geer, E. B. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02552 · Cited by 21
Lu, Q. R., Davel, A. P., McGraw, A. P., Rao, S., Newfell, B. G., & Jaffe, I. Z. (2019) · Endocrinology · doi:10.1210/en.2019-00258 · Cited by 21
Zhu, Q., Ge, F., Dong, Y., Sun, W., Wang, Z., Shan, Y., Chen, R., Sun, J., & Ge, R. (2018) · Steroids · doi:10.1016/j.steroids.2018.01.013 · Cited by 21
“HSD11B2, however, is mainly located in the mineralocorticoid receptor target tissues, such as kidney and salivary gland, where it acts a gate-keeper to inactivate cortisol and CORT by converting the steroids into cortisone and 11DHC, preventing them from occupying the mineralocorticoid receptors [8,9].”
Adipocyte Mineralocorticoid Receptor
Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.005 · Cited by 21
Yamazaki, O., Ishizawa, K., Hirohama, D., Fujita, T., & Shibata, S. (2019) · Clinical Science · doi:10.1042/cs20180194 · Cited by 21
Aldosterone-synthase overexpression in heart: a tool to explore aldosterone’s effects
Heymes, C., Garnier, A., Fuchs, S., Bendall, J. K., Nehmé, J., Ambroisine, M.-L., Robidel, E., Swynghedauw, B., Milliez, P., & Delcayre, C. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.022 · Cited by 21
Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome
Vogt, B., Dick, B., Marti, H.-P., Frey, F. J., & Frey, B. M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.5.753 · Cited by 21
Genetic analysis of 11β-hydroxysteroid dehydrogenase
White, P. C., Obeid, J. S., Agarwal, A. K., Tannin, G. M., & Nikkilä, H. (1994) · Steroids · doi:10.1016/0039-128x(94)90086-8 · Cited by 21
Dumeige, L., Storey, C., Decourtye, L., Nehlich, M., Lhadj, C., Viengchareun, S., Kappeler, L., Lombès, M., & Martinerie, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020457 · Cited by 21
“Thus, mineralocorticoid selectivity is ensured in epithelial target cells by the 11 β-hydroxysteroid dehydrogenase type 2 (11βHSD2) enzyme [16,17], which converts cortisol (or corticosterone in rodents) into inactive compounds : cortisone (or 11-dehydrocorticosterone in rodents).”
BackgroundQuirk, S. J., Slattery, J. A., & Funder, J. W. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90397-4 · Cited by 21
Self-citationPomper, M. G., Kochanny, M. J., Thieme, A. M., Carlson, K. E., VanBrocklin, H. F., Mathias, C. J., Welch, M. J., & Katzenellenbogen, J. A. (1992) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(92)90161-q · Cited by 21
Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat
Calogero, A. E., Liapi, C. A., & Chrousos, G. P. (1991) · Journal of Endocrinological Investigation · doi:10.1007/bf03346812 · Cited by 21
Distribution of 11β-hydroxysteroid dehydrogenase along the rat intestine
Pácha, J., & Mikšík, I. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90164-3 · Cited by 21
Govindan, M. V., Leclerc, S., Roy, R., Rathanaswami, P., & Xie, B. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90017-y · Cited by 21
Corticosteroid receptors and the central nervous system
Funder, J. W. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90283-6 · Cited by 21
Self-citationMaser, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90642-8 · Cited by 21
11β-Hydroxysteroid dehydrogenase and the meaning of life
Funder, J. W. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90163-3 · Cited by 21
Self-citationO’Hara, B., de la Rosa, D. Á., & Rajendran, V. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098695 · Cited by 20
Physiology and Regulation of the Renin–Angiotensin–Aldosterone System
Carey, R. M., & Padia, S. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00001-5 · Cited by 20
Forms of Mineralocorticoid Hypertension
Ferrari, P., & Bonny, O. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01004-5 · Cited by 20
Agarwal, A. K., Mune, T., Monder, C., & White, P. C. (1995) · Endocrine Research · doi:10.3109/07435809509030455 · Cited by 20
Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome
Armanini, D., Spinella, P., Simoncini, M., Basso, A., Zovato, S., Gb, P., Palo, C. B. D., Bucciante, G., & Karbowiak, I. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580435 · Cited by 20
“The corticosteroid receptors are of two types, Type I and Type II (Funder et al. 1988, Funder 1996).”
Adrenal corticosteroid action on the thick ascending limb.
Dietl, P., Good, D., & Stanton, B. A. (1990) · PubMed · Cited by 20
Hennebold, J. D., & Daynes, R. A. (1998) · Archives of Dermatological Research · doi:10.1007/s004030050328 · Cited by 20
“Functional expression of this catabolic enzyme in specific cellular sites within the kidney and testes is essential for proper organ function in the presence of normal endogenous levels of circulating GCs ( Funder et al. 1988; Monder et al. 1994).”
BackgroundMontrella-Waybill, M., Clore, J. N., Schoolwerth, A. C., Watlington, C. O., Whitworth, J. A., & Kelly, J. J. (1995) · Journal of Endocrinological Investigation · doi:10.1007/bf03349774 · Cited by 20
Mantero, F., Armanini, D., Boscaro, M., Carpené, G., Fallo, F., Opocher, G., Rocco, S., Scaroni, C. M., & Sonino, N. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90165-2 · Cited by 20
Rekka, E. A., Soldan, M., Bélai, I., Netter, K. J., & Maser, E. (1996) · Xenobiotica · doi:10.3109/00498259609047226 · Cited by 20
Mune, T., Morita, H., Suzuki, T., Takahashi, Y., Isomura, Y., Tanahashi, T., Daido, H., Yamakita, N., Deguchi, T., Sasano, H., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011335 · Cited by 20
Determinants of the heightened activity of glucocorticoid receptor translational isoforms
Bender, I. K., Cao, Y., & Lu, N. Z. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1009 · Cited by 19
“Tissue-selective expression of cofactors and glucocorticoid-metabolizing enzymes such as 11 -hydroxysteroid dehydrogenase 2 have been reported to contribute tissue specificity of glucocorticoid responses (33, 34).”
BackgroundSyndromes of glucocorticoid and mineralocorticoid resistance
Zennaro, M. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390127 · Cited by 19
Badran, M., Bender, S. B., & Gozal, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032245 · Cited by 19
“As a mechanism to confer the specificity of MR to aldosterone, the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) is co-expressed with MR and can metabolize cortisol to cortisone, which is unable to bind to or activate MR [126].”
ENaC Modulators and Renal Disease
de la Rosa, D. Á., Navarro‐González, J. F., & Giráldez, T. (2013) · Current Molecular Pharmacology · doi:10.2174/1874467211306010005 · Cited by 19
Koneru, B., Bathina, C. S., Cherry, B., & Mifflin, S. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00434.2013 · Cited by 19
“The MR has equal affinity for mineralocorticoids such as aldosterone as it does for glucocorticoids such as cortisol and corticosterone (4, 13).”
BackgroundEndocrine Disorders of Sodium Regulation
Kuhnle, U., Lewicka, S., & Fuller, P. J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075242 · Cited by 19
“The finding, described above, that the intrinsic affinity of the MR for cortisol was similar to its affinity for aldosterone led several investigators to invoke a ‘protective mechanism’ for the MR. It became clear that the enzyme 11β-hydroxysteroid dehydrogenase is primarily responsible for protecting the mineralocort…”
ResultAldosterone Antagonists in Heart Failure
Guglin, M. E., Kristof-Kuteyeva, O., Novotorova, I., & Pratap, P. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410387606 · Cited by 19
“The enzyme 11b-hydroxysteroid dehydrogenase type 2 (11b-HSD2) protects MR by converting cortisol to inactive cortisone.(52) However, in patients with HF, plasma glucocorticoid concentrations may be persistently elevated, resulting in high plasma cortisol concentrations and near constant MR activation.”
BackgroundCorticosteroid receptors and HPA-axis regulation
de Kloet, E. R., Schmidt, M. V., & Meijer, O. C. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80016-1 · Cited by 19
Jellinck, P. H., Dhabhar, F. S., Sakai, R. R., & McEwen, B. S. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00197-5 · Cited by 19
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.